For many patients, the end of active breast cancer treatment—the final infusion, the last radiation session, or...
Laily UPN
In a landmark achievement for reproductive medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
In the landscape of modern drug discovery, a quiet but profound revolution is taking place. For decades,...
In a paradigm-shifting discovery that challenges the conventional wisdom of "more oxygen is always better," researchers at...
The conclusion of active breast cancer treatment is often viewed by the medical community as a milestone...
By Editorial Staff, based on insights from Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information...
Introduction On July 23, 2026, the Department of Health and Human Services (HHS) finalized a sweeping regulatory...
For many patients, the end of active breast cancer treatment—chemotherapy, radiation, or surgery—is not the finish line,...
The biotechnology sector continues to navigate a complex landscape of regulatory scrutiny, clinical trial volatility, and strategic...
By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...
